IRIS Institutional Research Information System - OPENBS Open Archive UniBS

ARICI, Bruna
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.050
NA - Nord America 1.924
AS - Asia 1.525
SA - Sud America 315
AF - Africa 29
Continente sconosciuto - Info sul continente non disponibili 14
OC - Oceania 7
AN - Antartide 1
Totale 5.865
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.865
DE - Germania 626
CN - Cina 580
SG - Singapore 467
PL - Polonia 346
UA - Ucraina 345
BR - Brasile 262
IT - Italia 190
FI - Finlandia 132
HK - Hong Kong 121
IN - India 109
RU - Federazione Russa 105
GB - Regno Unito 91
VN - Vietnam 86
FR - Francia 72
TR - Turchia 60
IE - Irlanda 50
SE - Svezia 33
CA - Canada 29
MX - Messico 24
BD - Bangladesh 20
AR - Argentina 19
BE - Belgio 19
ID - Indonesia 15
EU - Europa 13
EC - Ecuador 12
IQ - Iraq 11
ZA - Sudafrica 10
JP - Giappone 9
AU - Australia 7
ES - Italia 7
NL - Olanda 7
PK - Pakistan 6
PY - Paraguay 6
AT - Austria 5
CZ - Repubblica Ceca 5
IR - Iran 5
KE - Kenya 5
SA - Arabia Saudita 5
CO - Colombia 4
RO - Romania 4
TH - Thailandia 4
AZ - Azerbaigian 3
EG - Egitto 3
LT - Lituania 3
MA - Marocco 3
MU - Mauritius 3
MY - Malesia 3
PE - Perù 3
RS - Serbia 3
UY - Uruguay 3
UZ - Uzbekistan 3
VE - Venezuela 3
AM - Armenia 2
BG - Bulgaria 2
BH - Bahrain 2
CL - Cile 2
IL - Israele 2
JO - Giordania 2
KZ - Kazakistan 2
OM - Oman 2
TN - Tunisia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AL - Albania 1
AQ - Antartide 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GT - Guatemala 1
HN - Honduras 1
HU - Ungheria 1
JM - Giamaica 1
LB - Libano 1
LK - Sri Lanka 1
NI - Nicaragua 1
NP - Nepal 1
PA - Panama 1
PS - Palestinian Territory 1
PT - Portogallo 1
SD - Sudan 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SR - Suriname 1
TW - Taiwan 1
TZ - Tanzania 1
Totale 5.865
Salva come PNG Salva come JPEG
Città #
Warsaw 346
Jacksonville 239
Singapore 224
Ashburn 142
Beijing 140
Hong Kong 118
Chandler 115
Fairfield 114
Woodbridge 105
Ann Arbor 102
Nanjing 96
Princeton 96
Wilmington 81
Helsinki 79
New York 79
Houston 73
Cambridge 62
Dearborn 49
Dublin 49
Los Angeles 46
Istanbul 45
Seattle 43
Brescia 35
Nanchang 35
Munich 34
Ho Chi Minh City 30
Shenyang 27
Buffalo 25
Changsha 24
Des Moines 24
Tianjin 24
Hebei 22
The Dalles 21
Jinan 20
São Paulo 19
San Francisco 18
Brussels 17
Milan 17
Pune 16
Jiaxing 15
Moscow 14
Toronto 13
Dong Ket 12
Hanoi 12
Lancaster 12
Shanghai 12
Hangzhou 11
Kocaeli 11
Kunming 11
Falkenstein 9
Mexico City 9
North York 9
Nürnberg 9
Redondo Beach 9
Chicago 8
Dallas 8
Guangzhou 8
Rio de Janeiro 8
San Diego 8
Verona 8
Brooklyn 7
Ningbo 7
Belo Horizonte 6
Jakarta 6
Johannesburg 6
Tokyo 6
Turku 6
Zhengzhou 6
Baghdad 5
Boardman 5
Dhaka 5
Guayaquil 5
Haikou 5
Nuremberg 5
Santa Clara 5
Taizhou 5
Atlanta 4
Campinas 4
Hefei 4
Juiz de Fora 4
London 4
Melbourne 4
Nairobi 4
Napoli 4
Phoenix 4
Sorocaba 4
Thái Bình 4
Annapolis 3
Asunción 3
Borås 3
Boston 3
Castelnuovo Bozzente 3
Charlotte 3
Chennai 3
Curitiba 3
Kolkata 3
Lanzhou 3
Montreal 3
Norwalk 3
Orange 3
Totale 3.240
Salva come PNG Salva come JPEG
Nome #
Sorafenib induces variations of the DNA methylome in HA22T/VGH human hepatocellular carcinoma-derived cells 314
Proteomic identification of LASP-1 down-regulation after RNAi urokinase silencing in human hepatocellular carcinoma cells. 255
Clinical and biological significance of miR-23b and miR-193a in human hepatocellular carcinoma 233
Effects of miR-193a and sorafenib on hepatocellular carcinoma cells. 207
miR-193a sensitizes hepatocellular carcinoma cells to sorafenib and impairs their aggressive properties. 182
Preparazione di colture primarie di fibroblasti di embrione di pollo . 173
MicroRNAs as Biomarkers of hepatocellular carcinoma and molecular targeted therapeutics with sorafenib 167
microRNAs and human hepatocellular carcinoma 165
LASP1 directly interacts with vimentin and its expression stratifies patients affected by human hepatocellular carcinoma 154
miR24, MiR 27a e miR193a nell'HCC: potenzialità prognostiche e terapeutiche. 144
In vitro c-met inhibition by antisense RNA and plasmid -based RNAi down modulates migration and invasion of hepatocellular carcinoma cells. 142
MicroRNA 193a negatively regulates urokinase and in combination with sorafenib impairs the aggressive properties of HCC cells 142
miR-193a sensitizes hepatocellular carcinoma cells to sorafenib and impairs their aggressive properties. 132
Antisense u-PA mRNA strategy inhibits the proliferation and invasion of human hepatocellular carcinoma cells. 130
The combined use of miR-193a and sorafenib displays in vitro anticancer effects in hepatocellular carcinoma. 125
"Trasformazione indotta dai virus oncogeni ad RNA. Tecniche di produzione e titolazione del RSV in colture di fibroblasti di embrione di pollo" pp. 27- 34, settembre 1987, in: , CLEUP-Padova, Italia. 122
MicroRNA-23b mediates urokinase and c-met downmodulation and a decreased migration of human hepatocellular carcinoma cells. 121
Urokinase and c-met are target of miR-23b in human cells. 115
Characterization and development of miRNA-like shRNA for urokinase targeting in human hepatocellular carcinoma 114
Stable expression of siRNA for urokinase gene in human hepatocellular carcinoma. 113
Urokinase targeting in human hepatocellular carcinoma by shRNAs/miR-23b and proteomic identification of LASP1 as uPA effector. 108
RNA interference against urokinase in hepatocellular carcinoma xenografts in nude mice. 107
MicroRNA ed Epatocarcinoma: il microRNA-23b media la downmodulazione di urochinasi e c-met e la capacità di migrazione di cellule derivate da HCC 107
Il silenziamento di urochinasi in cellule tumorali epatiche determina la downmodulazione di Lasp-1 106
Downregulation of urokinase by antisense and RNAi strategies inhibits the proliferation and migration of human hepatocellular carcinoma cells. 105
Espressione stabile di siRNA per il gene urochinasi nell'epatocarcinoma cellulare 103
Tecniche di conservazione delle cellule mediante congelamento. 103
MicroRNA-23b downmodulates urokinase and c-met and inhibits migration of human hepatocellular carcinoma cells. 102
L'espressione stabile della sequenza antisenso dell'mRNA dell'u-PA inibisce la proliferazione e l'invasione di cellule di epatocarcinoma umano. 100
L'espressione stabile di RNA antisenso e di siRNA per u-PA inibisce la proliferazione , la migrazione e l'invasione di cellule di epatocarcinoma umano. 100
Specific downregulation of urokinase by stable expression of antisense u-PA mRNA and u-PA siRNA inhibits proliferation, invasion,and migration of human hepatocellular carcinoma. 99
Il microRNA-23b media la downmodulazione di urochinasi e met ed inibisce la migrazione di cellule umane derivate da epatocarcinoma cellulare. 98
Molecular therapies for hepatocellular carcinoma: silencing of urokinase by antisense and siRNA stable u-PA expression. 98
MET silencing in human hepatocellular carcinoma: antisense and RNA interference 97
MicroRNA-23b negatively regulates urokinase and c-met and inhibits migration of human hepatocellular carcinoma cells. 96
MicroRNA-23b mediates urokinase and MET downmodulation and inhibits migration of human hepatocellular carcinoma cells. 95
RNA interference per il gene urochinasi nell'epatocarcinoma cellulare umano 94
miR-23b regulates uPA and c-met expression and mediates inhibition of HCC cells migration and proliferation. 93
miR-23b down-regulates urokinase and c-met expression and inhibits migration of human hepatocellular carcinoma cells. 91
Targeted therapy for human hepatocellular carcinoma (HCC): RNA interference for urokinase targeting in HCC xenografts in nude mice 90
RNA interference for urokinase gene in human hepatocellular carcinoma 88
L'espressione stabile di siRNA per il gene urochinasi diminuisce la capacità invasiva e di migrazione di cellule di epatocarcinoma cellulare umano. 87
RNA interference for urokinase targeting limits growth of hepatocellular carcinoma xenografts in nude mice 86
Stable expression of siRNA for urokinase gene in human hepatocellular carcinoma 85
Molecular therapies for hepatocellular carcinoma: silencing of urokinase by antisense and siRNA stable u-PA expression. 85
Profilo proteomico di cellule umane tumorali epatiche dopo silenziamento genico di urochinasi mediante RNAi 83
Strategie ablative per il silenziamento genico di c-met nell'epatocarcinoma cellulare umano: tecnologia antisenso ed RNAi. 81
Molecular therapies for hepatocellular carcinoma: silencing of urokinase-type plasminogen activator by antisense and siRNA stable u-PA expression 81
The down-modulation of miR-23b in hepatocellular carcinoma is mediated by DNA methylation 40
Totale 5.958
Salva come PNG Salva come JPEG
Categoria #
all - tutte 23.859
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.859
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021407 0 0 0 0 0 68 19 81 109 55 54 21
2021/2022356 9 66 10 26 2 9 10 23 17 35 50 99
2022/2023339 61 13 13 32 31 88 0 24 45 2 15 15
2023/2024361 20 12 28 10 26 90 36 7 72 6 4 50
2024/2025849 2 19 4 117 83 114 44 15 117 33 162 139
2025/2026978 174 234 131 241 166 32 0 0 0 0 0 0
Totale 5.958